Accordingly, this study's novelty and aim lie in the investigation of the therapeutic effect of rh-Endo plus NACT for OSA and its influence on serum VEGF and MMP-9 levels. The gene discussed is MMP9; the disease is obstructive sleep apnea syndrome.